FDA Inspection 1257703 — Sun Pharma Canada Inc.
The FDA completed an inspection of Sun Pharma Canada Inc. on Sep 20, 2024 in Brampton. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 20, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Brampton (Canada)
Additional details
Bioanalytical BA/BE